Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Therapeutic agents for gastrointestinal disorders claimed in recent patent literature

March 2, 2006

NPS to advance development of teduglutide for Crohn's disease

March 2, 2006

FDA approval for Zegerid Capsules

March 1, 2006

SM-360320: targeting TLR7 for HCV therapy

March 1, 2006

Inotek advances IMS into phase I study

Feb. 27, 2006

Actilon begins new phase II study in chronic hepatitis C infection

Feb. 27, 2006

NICE recommends Pegasys for first-line treatment of chronic hepatitis B

Feb. 27, 2006

Itax international phase III study fails to meet primary endpoint

Feb. 24, 2006

Novel agents for gastrointestinal disorders disclosed in recent patent literature

Feb. 23, 2006

Cerimon licenses Simulect for IBD from Novartis

Feb. 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...